$heff's $tation of $tocks & $olid DD

[My 2 Cents]

Sheff Station Certified: AEMD

Moving toward large scale production/commercialization!


Aethlon Medical Initiates Relationship to Establish Large Scale Production of Hemopurifier(R) Affinity Agents

Source: Aethlon Medical, Inc.
On Tuesday September 22, 2009, 8:00 am EDT

SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD - News) today announced that it has initiated a relationship with Kentucky Bioprocessing LLC to establish processes to support large-scale production of the active affinity agents immobilized within the Aethlon Hemopurifier®. Such affinity agents allow the Hemopurifer® to selectively capture a broad-spectrum of viruses from blood and other fluids. The Hemopurifier® is the first-in-class medical device to selectively adsorb viruses and immunosuppressive particles from the bloodstream.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

"The relationship with Kentucky Bioprocessing represents an important step towards establishing the long-term commercial feasibility of our Hemopurifier®, stated Aethlon Medical CEO, Jim Joyce. "Beyond a significant cost reduction of our affinity agents, the relationship offers large yield production potential in time frames that could improve our response capability against viral outbreaks, including unforeseen bioterror and pandemic threats," concluded Joyce.

As part of the relationship, Kentucky Bioprocessing will establish and confirm the sequence of Aethlon's affinity agents and then conduct optimization studies to insure agent purity. The affinity agents will then be transported as cloned proteins to be expressed in and extracted from tobacco plants as a strategy to maximize production yields.

About Kentucky Bioprocessing LLC

Kentucky Bioprocessing (KBP) is a service provider in the biotechnology industry specializing in the expression, extraction and purification of proteins and other high value products from plants. We work with clients to develop and implement scalable and regulatory compliant production processes designed to result in commercially viable end products. Operating from our one of a kind facility located in Owensboro, Kentucky KBP combines a robust intellectual property portfolio with a professional team experienced in successfully producing dozens of proteins in both stable transgenic and transient plant based gene expression systems. Whether you are considering an expression method for a target protein or are in need of process development and production services, our experience and know how can help you to avoid costly and time consuming mistakes and speed the commercialization process. Additional information is available online at www.kbpllc.com

About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.